TR201005327A2 - Synergistic pharmaceutical formulations. - Google Patents
Synergistic pharmaceutical formulations.Info
- Publication number
- TR201005327A2 TR201005327A2 TR2010/05327A TR201005327A TR201005327A2 TR 201005327 A2 TR201005327 A2 TR 201005327A2 TR 2010/05327 A TR2010/05327 A TR 2010/05327A TR 201005327 A TR201005327 A TR 201005327A TR 201005327 A2 TR201005327 A2 TR 201005327A2
- Authority
- TR
- Turkey
- Prior art keywords
- pharmaceutical formulations
- synergistic pharmaceutical
- synergistic
- pharmaceutical compositions
- active ingredients
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000002195 synergetic effect Effects 0.000 title 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003613 bile acid Substances 0.000 abstract 1
- 239000011885 synergistic combination Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Mevcut buluş, safra asidi bağlayıcı gruba dahil etken maddelerin yeni bir sinerjik kombinasyonuna ve bunları içeren farmasötik bileşimlere ilişkindir.The present invention relates to a novel synergistic combination of active ingredients included in the bile acid binding group and pharmaceutical compositions containing them.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2010/05327A TR201005327A2 (en) | 2010-06-30 | 2010-06-30 | Synergistic pharmaceutical formulations. |
| PCT/TR2011/000165 WO2012002922A1 (en) | 2010-06-30 | 2011-06-29 | Synergistic pharmaceutical formulations of colesevelam and fenofibrate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2010/05327A TR201005327A2 (en) | 2010-06-30 | 2010-06-30 | Synergistic pharmaceutical formulations. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201005327A2 true TR201005327A2 (en) | 2012-01-23 |
Family
ID=44484842
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2010/05327A TR201005327A2 (en) | 2010-06-30 | 2010-06-30 | Synergistic pharmaceutical formulations. |
Country Status (2)
| Country | Link |
|---|---|
| TR (1) | TR201005327A2 (en) |
| WO (1) | WO2012002922A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103768023B (en) * | 2012-10-23 | 2016-12-07 | 北京泰德制药股份有限公司 | A kind of dry suspension of colesevelam and preparation method thereof |
| CN104906077B (en) * | 2014-03-12 | 2017-10-20 | 上海博邦医药科技有限公司 | A kind of fenofibrate choline salt controlled release preparation with two-phase drug release feature and preparation method thereof |
| KR102407512B1 (en) * | 2019-10-30 | 2022-06-13 | 주식회사 대웅테라퓨틱스 | Composition for preventing and treating muscular disease comprising fibrates |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4058552A (en) | 1969-01-31 | 1977-11-15 | Orchimed Sa | Esters of p-carbonylphenoxy-isobutyric acids |
| TW474813B (en) | 1994-06-10 | 2002-02-01 | Geltex Pharma Inc | Alkylated composition for removing bile salts from a patient |
| ATE369851T1 (en) | 2001-01-26 | 2007-09-15 | Schering Corp | COMBINATIONS OF BALE ACID SEQUESTRANTS AND STEROL ABSORPTION INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR INDICATIONS |
-
2010
- 2010-06-30 TR TR2010/05327A patent/TR201005327A2/en unknown
-
2011
- 2011-06-29 WO PCT/TR2011/000165 patent/WO2012002922A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012002922A1 (en) | 2012-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JOP20180102A1 (en) | Pharmaceutical composition | |
| CL2016000188A1 (en) | Compositions of serpinc1 harness and methods of use thereof | |
| BR112012019190A2 (en) | oral care compositions. | |
| TR200806298A2 (en) | Pharmaceutical formulation | |
| EA201201298A1 (en) | FUNGICIDAL COMPOSITIONS CONTAINING A PHOSPHORABLE MICROORANISM AND FUNGICIDO ACTIVE CONNECTION | |
| PH12012500754A1 (en) | Pharmaceutical composition comprising oligopeptides | |
| FR2975004B1 (en) | NEW ANTI-REDNESS ACTIVE INGREDIENTS AND COSMETIC COMPOSITIONS COMPRISING THE SAME | |
| PH12012501620A1 (en) | Oral care compositions | |
| NZ708821A (en) | Lfa-1 inhibitor formulations | |
| MX342947B (en) | Treatment of type 2 diabetes. | |
| BR112012032882A2 (en) | increased release of lopophilic ingredients from hydrocolloid chewing gum | |
| TR201903918T4 (en) | Compositions containing a dispersing agent and their preparation. | |
| WO2012002730A3 (en) | Skin-whitening and skin-moisturizing composition containing bee venom extracts | |
| IN2014DN02926A (en) | ||
| MY163476A (en) | Oral care compositions | |
| TR200908237A2 (en) | Pharmaceutical compositions containing calcium and vitamin D. | |
| TR200900879A2 (en) | Pharmaceutical compositions in which the active ingredients are combined in a single dosage form | |
| TR201009167A2 (en) | Pharmaceutical granules containing cephalosporin. | |
| TR201009394A2 (en) | Improved montelukast formulations. | |
| WO2012093973A3 (en) | Compositions in the form of tablets comprising acarbose | |
| TR201005327A2 (en) | Synergistic pharmaceutical formulations. | |
| CO6680629A2 (en) | Compounds with antibacterial activity against clsotridium | |
| TR200909785A1 (en) | Pharmaceutical compositions containing cefdinir as the active agent. | |
| TR201007250A2 (en) | Formulation containing cellobiose. | |
| WO2012007758A3 (en) | Pharmaceutical formulations |